Veterinary Medicines

RABISIN, injekcinė suspensija

Authorised
  • Rabies virus, strain G52, Inactivated
Download as PDF

Product identification

Medicine name:
RABISIN, injekcinė suspensija
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Dog
  • Cat
  • Horse
  • Cattle
  • Sheep
  • Ferret
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/95/0250/001-004
Date of authorisation status change:

Documents

RV0250.pdf

Lithuanian (PDF)
Published on: 28/06/2022
Download